Volume 107, Issue s179 pp. 29-33

Cognitive deficits in preclinical Alzheimer's disease

Brent J. Small

Brent J. Small

Department of Gerontology, University of South Florida, Tampa, FL, USA;

Search for more papers by this author
Jennifer L. Mobly

Jennifer L. Mobly

Department of Gerontology, University of South Florida, Tampa, FL, USA;

Search for more papers by this author
Erika Jonsson Laukka

Erika Jonsson Laukka

Department of Psychology, Uppsala University, Uppsala, Sweden;

Division of Geriatric Epidemiology, Neurotec, Karolinska Institutet, Stockholm, Sweden

Search for more papers by this author
Sari Jones

Sari Jones

Department of Psychology, Uppsala University, Uppsala, Sweden;

Division of Geriatric Epidemiology, Neurotec, Karolinska Institutet, Stockholm, Sweden

Search for more papers by this author
Lars Bäckman

Lars Bäckman

Department of Psychology, Uppsala University, Uppsala, Sweden;

Division of Geriatric Epidemiology, Neurotec, Karolinska Institutet, Stockholm, Sweden

Search for more papers by this author
First published: 21 February 2003
Citations: 69
Brent J. Small, Department of Gerontology, SOC 107, University of South Florida, 4202 East Fowler Ave., Tampa, FL 33620, USA
Tel.: +1 813-974-9746
Fax: +1 813-974-9754
e-mail: [email protected]

Abstract

We review the literature on cognitive functioning during the transition from normal aging to clinical Alzheimer's disease (AD). There is ample empirical evidence that deficits across multiple cognitive domains are apparent years to decades before the AD diagnosis, with impairments in episodic memory representing a common cognitive manifestation of the preclinical phase of the disease. Interestingly, the magnitude of the preclinical cognitive deficits appears to be relatively stable until a few years before clinical diagnosis. The behavioural deficits associated with preclinical AD are consistent with the neural changes that appear many years before eventual diagnosis. In addition to increasing our theoretical understanding of AD development, research on cognition in preclinical AD contributes to the identification of persons at risk of developing AD for purposes of intervention.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.